Abridge sells an AI-powered clinical documentation platform for healthcare professionals, enhancing the accuracy and efficiency of patient interactions and documentation.
abridge.comLinkedInSan Francisco, CA
1 source
The announcement headline uses “a16z,” while the body names the lead as Andreessen Horowitz; the body is used for the investor name. ദsources agree
Published by hand (abridge.com): "Abridge Secures $300M Series E Led by a16z to Pioneer a New Paradigm of Care Intelligence": brand backfill: the cited page states the round's $300M
1 source
Published by hand (abridge.com): "Abridge Announces $250M Series D Investment and New Contextual Reasoning Engine to Streamline Clinical and Financial Workflows at the Point of Care": brand backfill: the cited page states the round's $250 million
1 source
Published by hand (abridge.com): "PITTSBURGH, PA (February 23, 2024) – Abridge, the leader in generative AI for clinical documentation, announced an additional $150 million investment, leveraging momentum from their product’s rapid uptake among health systems throughout the nation.": brand backfill: the cited page states the round's $150 million
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series E [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $300M | 2025-06-23 | Andreessen Horowitz | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source
The announcement headline uses “a16z,” while the body names the lead as Andreessen Horowitz; the body is used for the investor name. ദsources agree Published by hand (abridge.com): "Abridge Secures $300M Series E Led by a16z to Pioneer a New Paradigm of Care Intelligence": brand backfill: the cited page states the round's $300M | ||||
| Series D [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $250M | 2025-02-17 | Elad Gil, IVP | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source
Published by hand (abridge.com): "Abridge Announces $250M Series D Investment and New Contextual Reasoning Engine to Streamline Clinical and Financial Workflows at the Point of Care": brand backfill: the cited page states the round's $250 million [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: abridge.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage | ||||
| Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2024-02-23 | Lightspeed | No recent discussion |
1 source [ VERIFIED ] read against 1 source Published by hand (abridge.com): "PITTSBURGH, PA (February 23, 2024) – Abridge, the leader in generative AI for clinical documentation, announced an additional $150 million investment, leveraging momentum from their product’s rapid uptake among health systems throughout the nation.": brand backfill: the cited page states the round's $150 million [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: abridge.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage | ||||